title: Surgery for liver metastases from breast cancer.
abstract: BACKGROUND
  Liver metastases from breast cancer (BCLM) confer poor survival. Liver resection in BCLM patients has been increasingly employed.
  
  
  OBJECTIVE
  We undertook a systematic review to evaluate the role of hepatic resection in patients with breast cancer metastatic to the liver.
  
  
  METHODS
  In total, 36 studies were overviewed. Patient populations, characteristics, morbidity, mortality and survival were documented.
  
  
  RESULTS
  Median overall survival was 41 months. Major morbidity was rare while 30-day postoperative mortality was near nil.
  
  
  CONCLUSIONS
  Liver surgery for BCLM can be performed with low mortality, acceptable morbidity and promising survival benefit in carefully selected patients.
authors.affiliation: Breast Unit, Second Propedeutic Department of Surgery, Laiko General Hospital, Athens University School of Medicine, Athens, Greece.
authors.forename: Petros
authors.initials: P
authors.lastname: Charalampoudis
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Mantas
authors.forename: Georgios C
authors.initials: GC
authors.lastname: Sotiropoulos
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Dimitroulis
authors.forename: Gregory
authors.initials: G
authors.lastname: Kouraklis
authors.forename: Christos
authors.initials: C
authors.lastname: Markopoulos
mesh_terms: D001943:Breast Neoplasms / Q000453:epidemiology / Q000401:mortality / Q000473:pathology*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000453:epidemiology / Q000401:mortality / Q000556:secondary* / Q000601:surgery*; D009017:Morbidity; D009026:Mortality; D019233:Retreatment; D016896:Treatment Outcome
keywords: breast cancer; chemotherapy; hepatectomy; liver metastases; metastasectomy; resection; surgery; survival